Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria.
Ranganath LR, Milan AM, Hughes AT, Davison AS, Khedr M, Norman BP, Bou-Gharios G, Gallagher JA, Gornall M, Jackson R, Imrich R, Rovensky J, Rudebeck M, Olsson B. Ranganath LR, et al. Among authors: jackson r. Mol Genet Metab Rep. 2022 Feb 1;30:100846. doi: 10.1016/j.ymgmr.2022.100846. eCollection 2022 Mar. Mol Genet Metab Rep. 2022. PMID: 35242577 Free PMC article.
Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone.
Imrich R, Sedláková J, Úlehlová M, Gornall M, Jackson R, Olsson B, Rudebeck M, Gallagher J, Lukáčová O, Mlynáriková V, Stančík R, Vrtíková E, Záňová E, Zaťková A, Arnoux JB, Rovenský J, Luangrath E, Bygott H, Khedr M, Ranganath LR. Imrich R, et al. Among authors: jackson r. RMD Open. 2022 Oct;8(2):e002422. doi: 10.1136/rmdopen-2022-002422. RMD Open. 2022. PMID: 36270742 Free PMC article. Clinical Trial.
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies.
Braconi D, Geminiani M, Psarelli EE, Giustarini D, Marzocchi B, Rossi R, Bernardini G, Spiga O, Gallagher JA, Le Quan Sang KH, Arnoux JB, Imrich R, Al-Sbou MS, Gornall M, Jackson R, Ranganath LR, Santucci A. Braconi D, et al. Among authors: jackson r. Cells. 2022 Nov 18;11(22):3668. doi: 10.3390/cells11223668. Cells. 2022. PMID: 36429096 Free PMC article.
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Hussain SA, Lester JF, Jackson R, Gornall M, Qureshi M, Elliott A, Crabb SJ, Huddart RA, Vasudev N, Birtle AJ, Worlding J, James ND, Parikh O, Vilarino-Varela M, Alonzi R, Linch MD, Riaz IB, Catto JWF, Powles T, Jones RJ. Hussain SA, et al. Among authors: jackson r. Lancet Oncol. 2022 May;23(5):650-658. doi: 10.1016/S1470-2045(22)00158-9. Epub 2022 Apr 11. Lancet Oncol. 2022. PMID: 35421369 Free article. Clinical Trial.
5,552 results